{
    "Trade/Device Name(s)": [
        "N Antisera to Human Immunoglobulins (IgG, IgA, and IgM)",
        "N/T Protein Control LC"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Products GmbH",
    "510(k) Number": "K083445",
    "Predicate Device Reference 510(k) Number(s)": [
        "K951635",
        "K963974",
        "K042735",
        "K072435"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CFN",
        "JJY"
    ],
    "Summary Letter Date": "March 24, 2009",
    "Summary Letter Received Date": "February 13, 2009",
    "Submission Date": "November 6, 2008",
    "Regulation Number(s)": [
        "21 CFR 866.5510"
    ],
    "Regulation Name(s)": [
        "Immunoglobulins A, G, M, D, and E immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "IgG",
        "IgA",
        "IgM",
        "Transferrin",
        "Albumin",
        "a1-microglobulin",
        "Total protein"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Heparinized plasma",
        "EDTA plasma",
        "Urine",
        "Cerebrospinal fluid (CSF)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BN\u2122 Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Immunonephelometry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for N Antisera to Human Immunoglobulins (IgG, IgA, and IgM) and N/T Protein Control LC for quantitative determination and quality control of immunoglobulins and proteins in human serum, plasma, urine, and CSF by immunonephelometry using BN\u2122 Systems.",
    "Indications for Use Summary": "In vitro diagnostic reagents for quantitative determination of immunoglobulins (IgG, IgA, IgM) in human serum, plasma, urine, and CSF; N/T Protein Control LC intended as assayed quality control for assessment of precision and analytical bias in immunochemical determination of IgG, IgA, IgM, transferrin, albumin, a1-microglobulin, and total protein in urine and CSF using BN\u2122 Systems.",
    "fda_folder": "Immunology"
}